"MPS II, also known as Hunter Syndrome, has been a part of my life for as long as I can remember. I grew...
In the early days of his career, a young scientist named Emil Kakkis found himself deep in the world of...
The National MPS Society is pleased to share an update on RGX-121, an investigational gene therapy for MPS II...
After recent successful meetings with the FDA, Denali Therapeutics announced its plan to file for accelerated...
Matthew Ellinwood, Chief Scientific Officer, authored a new publication published in the American Journal of...
Click here to download full text.Durham, NC August 3, 2022 - The National MPS Society announces that...
